相关实验视频

Updated: Jul 12, 2025

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy

Published on: August 1, 2013

对瘤蛋白D52作为癌症疫苗抗原的临床前支持

Robert K Bright¹

¹Department of Immunology and Molecular Microbiology, School of Medicine and Cancer Center, Texas Tech University Health Sciences Center, Lubbock, TX, USA.

Human vaccines & immunotherapeutics

|October 31, 2023

概括

针对瘤相关抗原 (TAA) 的疫苗诱导免疫力瘤蛋白D52 (TPD52) 在临床前模型中有效准多种癌症. 这种方法对癌症治疗有希望,而不会在健康组织中引起自身免疫.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
分子生物学分子生物学

背景情况:

与瘤相关的抗原 (TAA) 是与正常组织相比,在癌细胞中过度表达的蛋白质.
瘤蛋白D52 (TPD52) 是一种TAA,涉及癌细胞转化,增殖和转移.
在许多成人和儿科恶性瘤中观察到TPD52过度表达.

研究的目的:

评估临床前疫苗诱导免疫力对TPD52 (mD52) 的小鼠骨科对象在治疗各种癌症中的有效性.
评估mD52向免疫的安全性,特别研究对健康组织缺乏自身免疫.

主要方法:

临床前研究是在15年内使用小鼠模型进行的.
诱导了对mD52的免疫力,mD52是人类TPD52的小鼠对应物.
在各种癌症模型中评估了疗效和安全性 (自身免疫性).

主要成果:

针对mD52的疫苗诱导免疫在小鼠模型中证明了对多种癌症类型的有效性.
诱导免疫没有导致对健康组织和细胞的自身免疫.
研究跨越了15年的临床前研究.

结论:

通过疫苗诱导免疫来向瘤蛋白D52 (TPD52) 是一种可行的临床前策略,用于广泛的癌症治疗.
这种免疫疗法方法显示了有效向癌症的潜力,而不会产生不良的自身免疫效应.
基于TPD52的疫苗的进一步开发可能为各种恶性瘤提供新的治疗途径.

关键词:

在 TPD52 (D52) 中.hD52 (人体 ортолог TPD52) 的情况.mD52 (小鼠 ортолог TPD52) 进行检查.瘤原性瘤性瘤性瘤性瘤性过度表达的瘤自身抗原.分享的共享共享的共享.这是一个普遍的,普遍的,普遍的.疫苗疫苗疫苗疫苗

更多相关视频

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Published on: January 6, 2014

相关概念视频

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.